A Single Oral Dose Study of ASP015K in Healthy Volunteers Assessing the Relative Bioavailability Across Three Tablet Strengths From a New Formulation of ASP015K
PHASE1CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
September 30, 2011
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2011
Conditions
Bioavailability of ASP015KPharmacokinetics of ASP015KHealthy Subjects